DJIA 16,979.13 59.54 0.35%
NASDAQ 4,526.48 -1.03 -0.02%
S&P 500 1,986.51 4.91 0.25%
market minute promo

19.03 0.02 (0.11%)

Quote as of

Extended Hours: $19.03 $0.00 (0.00%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

OMED $19.03 0.11%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $19.32
Previous Close $19.01
Daily Range $18.81 - $19.39
52-Week Range $12.07 - $42.34
Market Cap $566.3M
P/E Ratio 1.37
Dividend (Yield) $0.00 (0.0%)
Volume 166,631
Average Daily Volume 150,455
Current FY EPS -$1.59

Sector

Industry

ONCOMED PHARMACEUTICALS INC (OMED) Description

ONCOMED PHARMACEUTICALS INC Website: http://www.oncomed.com/

News & Commentary

Why Oncotheryeon, Inc., OncoMed Pharmaceuticals, Inc., and Array BioPharma Inc. Stocks Jumped Today

Three biotechs climb after a competitor's trial success boosts hope across the HER-2 breast cancer treatment market

OncoMed Pharmaceuticals Slumps: OMED Plunges 10.2% in Session - Tale of the Tape

Commit To Buy OncoMed Pharmaceuticals At $17.50, Earn 24.7% Annualized Using Options

4 Biotech Stocks Breaking Out on Big Volume

OncoMed Pharmaceuticals Initiates Randomized Phase 2 "ALPINE" Clinical Trial Of Tarextumab (Anti-Not

OncoMed Pharmaceuticals Initiates Randomized Phase 2 "ALPINE" Clinical Trial Of Tarextumab (Anti-Notch 2/3, OMP-59R5) For Pancreatic Cancer

OncoMed's OMP-54F28 on Partial Clinical Hold - Analyst Blog

OncoMed's OMP-18R5 On Clinical Hold, Shares Down - Analyst Blog

OncoMed's OMP-18R5 On Clinical Hold, Shares Down - Analyst Blog

Why OncoMed Pharmaceuticals Inc. Shares Surged

OncoMed shares reverse course from Friday's swoon despite the release of mixed news from the company.

OncoMed Pharmaceuticals (OMED) Falls: Stock Tumbles 8.8% - Tale of the Tape

This Week in Biotech: Tulipmania Ensues in the Hepatitis C Sector

Five clinical updates that made waves in the biotech sector this week, as well as the surprising buyout that still has Wall Street abuzz.

See More OMED News...